Publications

  • Irie F, Matsuo R, Mezuki S, Wakisaka Y, Kamouchi M, Kitazono T, Ago T; Fukuoka Stroke Registry Investigators.
    Effect of smoking status on clinical outcomes after reperfusion therapy for acute ischemic stroke.
    Sci Rep. 2024;14:9290.
  • Irie F, Matsumoto K, Matsuo R, Nohara Y, Wakisaka Y, Ago T, Nakashima N, Kitazono T, Kamouchi M
    Predictive performance of machine learning–based models for poststroke clinical outcomes in comparison with conventional prognostic scores: multicenter, hospital-based observational study
    JMIR AI 3:e46840
  • Wakisaka K, Matsuo R, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
    Association between abdominal adiposity and clinical outcomes in patients with acute ischemic stroke.
    PLoS One. 2024 Jan 11;19(1):e0296833.
    脳梗塞発症時に腹囲が大きい患者では、BMIやインスリン抵抗性とは独立して、3ヵ月後機能予後良好と有意に関連していた。
  • Mezuki S, Matsuo R, Irie F, Shono Y, Kuwashiro T, Sugimori H, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
    Body temperature in the acute phase and clinical outcomes after acute ischemic stroke.
    PLoS One. 2024 Jan 11;19(1):e0296639.
    虚血性脳卒中発症後7日間の平均体温の5分位値を用いた検討では、入院時重症度、CRP、感染症などの交絡因子を調整後も、平均体温が高いほど臨床経過(入院後の神経症状改善または増悪)、および3ヵ月後機能転帰が不良であった。
  • Nakamura K, Ueki K, Matsuo R, Kiyohara T, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Investigators for Fukuoka Stroke Registry.
    Association between decreases in serum uric acid levels and unfavorable outcomes after ischemic stroke: A multicenter hospital-based observational study
    PLoS One. 2023 Jun 29;18(6):e0287721.
    急性期脳梗塞において、入院後の血清尿酸値の低下は、発症3ヶ月後の機能転帰不良と有意に関連する。
  • Wakisaka K, Matsuo R, Matsumoto K, Nohara Y, Irie F, Wakisaka Y, Ago T, Nakashima N, Kamouchi M, Kitazono T.
    Non-linear association between body weight and functional outcome after acute ischemic stroke.
    Sci Rep. 2023 May 29;13(1):8697.
    正常体重群と比較して、低体重群では急性期虚血性脳卒中発症3ヵ月後の機能予後不良となるリスクは有意に上昇し、過体重群では有意にリスクが低下したが、肥満群では有意な関連を示されなかった。
  • Ueki K, Matsuo R, Kuwashiro T, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
    Decreased Estimated Glomerular Filtration Rate and Proteinuria and Long-Term Outcomes After Ischemic Stroke: A Longitudinal Observational Cohort Study
    Stroke. 2023 Apr 6. doi: 10.1161/STROKEAHA.122.040958. Epub ahead of print. PMID: 37021567.
    腎機能低下(eGFRの低下)や腎障害(蛋白尿)は、虚血性脳卒中発症後の長期における脳卒中再発と死亡の互いに独立した危険因子である。
  • Ohya Y, Matsuo R, Sato N, Irie F, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Investigators for Fukuoka Stroke Registry.
    Modification of the effects of age on clinical outcomes through management of lifestyle-related factors in patients with acute ischemic stroke.
    J Neurol Sci. 2023 Feb 15;446:120589.
    高年齢は、臨床的特徴、臨床病型、超急性期血栓溶解療法とは無関係に、脳梗塞発症後の臨床経過(入院後の神経症状改善または増悪)、および3ヵ月後機能転帰不良と有意に関連する。この関連は、女性、低体重、高血圧、糖尿病がある場合により強くなる可能性がある。
  • Irie F, Matsuo R, Nakamura K, Wakisaka Y, Ago T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Sex Differences in Long-Term Functional Decline after Ischemic Stroke: A Longitudinal Observational Study from the Fukuoka Stroke Registry.
    Cerebrovasc Dis. 2023 Feb 8:1-8.
  • Ohya Y, Matsuo R, Sato N, Irie F, Nakamura K, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Investigators for Fukuoka Stroke Registry.
    Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study.
    PLoS One. 2022 Jul 13;17(7):e0268481.
    若年成人の脳梗塞は、非若年成人と比べて他の原因による脳梗塞(other determined etiology)や原因不明の脳梗塞(undetermined etiology)が多いが、高血圧、糖尿病、脂質異常症といった従来の危険因子や、喫煙、飲酒、肥満といった生活習慣に関連した因子は年齢が上がるにつれて増加するため、若年成人においても軽視することはできない。
  • Fukuda K, Matsuo R, Kamouchi M, Kiyuna F, Sato N, Nakamura K, Hata J, Wakisaka Y, Ago T, Imaizumi T, Kai H, Kitazono T; FSR Investigators.
    Day-by-Day Blood Pressure Variability in the Subacute Stage of Ischemic Stroke and Long- Term Recurrence.
    Stroke. 2022 Jan;53(1):70-78.
    虚血性脳卒中の亜急性期における血圧の日内変動は、長期的な脳卒中再発および全死亡の独立した予測因子である。
  • Irie F, Matsuo R, Nakamura K, Wakisaka Y, Ago T, Kamouchi M, Kitazono T, Fukuoka Stroke Registry Investigators
    Sex Differences in the Risk of 30-Day Death After Acute Ischemic Stroke
    Neurol Clin Pract. 2021 Dec;11(6):e809-e816
  • Wakisaka Y, Matsuo R, Nakamura K, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
    Pre-Stroke Cholinesterase Inhibitor Treatment Is Beneficially Associated with Functional Outcome in Patients with Acute Ischemic Stroke and Pre-Stroke Dementia: The Fukuoka Stroke Registry.
    Cerebrovasc Dis. 2021;50(4):390-396.
  • Kiyohara T, Matsuo R, Hata J, Nakamura K, Wakisaka Y, Kamouchi M, Kitazono T, Ago T; FSR Investigators.
    β-Cell Function and Clinical Outcome in Nondiabetic Patients With Acute Ischemic Stroke.
    Stroke. 2021;52(8):2621-2628.
    非糖尿病患者の急性期脳梗塞発症時における膵β細胞の機能低下(低HOMA-β)は、インスリン抵抗性と独立して、3ヵ月後機能予後不良および急性期増悪の危険因子である。
  • Matsuo R, Ago T, Kiyuna F, Sato N, Nakamura K, Kuroda J, Wakisaka Y, Kitazono T; Fukuoka Stroke Registry Investigators.
    Smoking Status and Functional Outcomes After Acute Ischemic Stroke.
    Stroke. 2020;51(3):846-852.
  • Sato N, Matsuo R, Kiyuna F, Nakamura K, Hata J, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; collab on behalf of the Fukuoka Stroke Registry Investigators.
    Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism.
    Cerebrovasc Dis.2020;49(6):601-608.
  • Kuroda J, Matsuo R, Yamaguchi Y, Sato N, Kamouchi M, Hata J, Wakisaka Y, Ago T, Kitazono T; Fukuoka Stroke Registry Investigators.
    Poor glycemic control and posterior circulation ischemic stroke.
    Neurol Clin Pract. 2019;9(2):129-139.
  • Shono Y, Sugimori H, Matsuo R, Fukushima Y, Wakisaka Y, Kuroda J, Ago T, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
    Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm.
    Int J Stroke. 2018; 13(7):734-742.
  • Ago T, Matsuo R, Hata J, Wakisaka Y, Kuroda J, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Insulin resistance and clinical outcomes after acute ischemic stroke.
    Neurology. 2018; 90(17): e1470-1477.
    虚血性脳卒中急性期のHOMA-IRの5分位値を用いた検討では、高HOMA-IRは神経学的予後(入院中の神経学的重症度の改善または増悪)、および3ヵ月後機能転帰不良の危険因子であった。この関連は、糖尿病や非肥満患者でも同様に示された。
  • Kiyuna F, Sato N, Matsuo R, Kamouchi M, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T; Fukuoka Stroke Registry Investigators.
    Association of Embolic Sources With Cause-Specific Functional Outcomes Among Adults With Cryptogenic Stroke.
    JAMA Netw Open. 2018;1(5):e182953.
  • Ogata T, Matsuo R, Kiyuna F, Hata J, Ago T, Tsuboi Y, Kitazono T, Kamouchi M; FSR Investigators.
    Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.
    J Am Heart Assoc. 2017; 6.
  • Wakisaka Y, Matsuo R, Hata J, Kuroda J, Kitazono T, Kamouchi M, Ago T; Fukuoka Stroke Registry Investigators.
    Adverse Influence of Pre-Stroke Dementia on Short-Term Functional Outcomes in Patients with Acute Ischemic Stroke: The Fukuoka Stroke Registry.
    Cerebrovasc Dis. 2017;43(1-2):82-89.
  • Matsuo R, Yamaguchi Y, Matsushita T, Hata J, Kiyuna F, Fukuda K, Wakisaka Y, Kuroda J, Ago T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Association Between Onset-to-Door Time and Clinical Outcomes After Ischemic Stroke.
    Stroke. 2017;48:3049-3056.
  • Ishikawa H, Wakisaka Y, Matsuo R, Makihara N, Hata J, Kuroda J, Ago T, Kitayama J, Nakane H, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.
    Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry.
    Cerebrovasc Dis. 2016; 42(5-6): 395-403.
  • Matsuo R, Michikawa T, Ueda K, Ago T, Nitta H, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Short-Term Exposure to Fine Particulate Matter and Risk of Ischemic Stroke.
    Stroke. 2016;47(12):3032-3034.
  • Matsuo R, Ago T, Hata J, Wakisaka Y, Kuroda J, Kuwashiro T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study.
    PLoS One. 2016;11(6):e0156790.
  • Nakamura A, Kuroda J, Ago T, Hata J, Matsuo R, Arakawa S, Kuwashiro T, Yasaka M, Okada Y, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.
    Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
    Cerebrovasc Dis. 2016;42(3-4):196-204.
  • Fukuda K, Kai H, Kamouchi M, Hata J, Ago T, Nakane H, Imaizumi T, Kitazono T; FSR Investigators; steering committee of the Fukuoka Stroke Registry included.
    Day-by-Day Blood Pressure Variability and Functional Outcome After Acute Ischemic Stroke: Fukuoka Stroke Registry.
    Stroke. 2015;46(7):1832-9.
  • Irie F, Kamouchi M, Hata J, Matsuo R, Wakisaka Y, Kuroda J, Ago T, Kitazono T; FSR Investigators.
    Sex differences in short-term outcomes after acute ischemic stroke: the fukuoka stroke registry.
    Stroke. 2015;46(2):471-6.
  • Matsuo R, Kamouchi M, Fukuda H, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T; FSR Investigators.
    Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry.
    PLoS One. 2014;9(10):e110444.
  • Ogata T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Ago T, Sugimori H, Inoue T, Kitazono T; Fukuoka Stroke Registry.
    Gastrointestinal bleeding in acute ischemic stroke: recent trends from the fukuoka stroke registry.
    Cerebrovasc Dis Extra. 2014;4(2):156-64.
  • Wakisaka Y, Ago T, Kamouchi M, Kuroda J, Matsuo R, Hata J, Gotoh S, Isomura T, Awano H, Suzuki K, Fukuda K, Okada Y, Kiyohara Y, Ooboshi H, Kitazono T; REBIOS Investigators.
    Plasma S100A12 is associated with functional outcome after ischemic stroke: Research for Biomarkers in Ischemic Stroke.
    J Neurol Sci. 2014;340(1-2):75-9.
  • Matsuo R, Kamouchi M, Ago T, Hata J, Shono Y, Kuroda J, Wakisaka Y, Sugimori H, Kitazono T; FSR investigators.
    Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Geriatr Gerontol Int. 2014;14(4):954-9.
  • Ishitsuka K, Kamouchi M, Hata J, Fukuda K, Matsuo R, Kuroda J, Ago T, Kuwashiro T, Sugimori H, Nakane H, Kitazono T; FSR Investigators.
    High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: Fukuoka Stroke Registry.
    Hypertension. 2014;63(1):54-60.
  • Kiyohara T, Kamouchi M, Kumai Y, Ninomiya T, Hata J, Yoshimura S, Ago T, Okada Y, Kitazono T; Fukuoka Stroke Registry Investigators.
    ABCD3 and ABCD3-I scores are superior to ABCD2 score in the prediction of short- and long-term risks of stroke after transient ischemic attack.
    Stroke. 2014;45(2):418-25.
  • Kuwashiro T, Ago T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Fukuda K, Sugimori H, Fukuhara M, Awano H, Isomura T, Suzuki K, Yasaka M, Okada Y, Kiyohara Y, Kitazono T.
    Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke – Research for Biomarkers in Ischemic Stroke (REBIOS).
    Metabolism. 2014;63(9):1093-103.
  • Matsuo R, Ago T, Hata J, Kuroda J, Wakisaka Y, Sugimori H, Kitazono T, Kamouchi M; FSR Investigators.
    Impact of the 1425G/A polymorphism of PRKCH on the recurrence of ischemic stroke: Fukuoka Stroke Registry.
    J Stroke Cerebrovasc Dis. 2014;23(6):1356-61.
  • Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T.
    The impact of predisposing factors on long-term outcome after stroke in diabetic patients: the Fukuoka Stroke Registry.
    Eur J Neurol. 2013;20(6):921-7.
  • Kamouchi M, Sakai H, Kiyohara Y, Minematsu K, Hayashi K, Kitazono T.
    Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
    J Stroke Cerebrovasc Dis. 2013;22(8):e470-6.
  • Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T; FSR Investigators.
    Predictive role of C reactive protein in stroke recurrence after cardioembolic stroke: the Fukuoka Stroke Registry.
    BMJ Open.2013;3(11):e003678.
  • Makihara N, Kamouchi M, Hata J, Matsuo R, Ago T, Kuroda J, Kuwashiro T, Sugimori H, Kitazono T; Fukuoka Stroke Registry Investigators.
    Statins and the risks of stroke recurrence and death after ischemic stroke: the Fukuoka Stroke Registry.
    Atherosclerosis. 2013;231(2):211-5.
  • Matsuo R, Ago T, Kamouchi M, Kuroda J, Kuwashiro T, Hata J, Sugimori H, Fukuda K, Gotoh S, Makihara N, Fukuhara M, Awano H, Isomura T, Suzuki K, Yasaka M, Okada Y, Kiyohara Y, Kitazono T.
    Clinical significance of plasma VEGF value in ischemic stroke – research for biomarkers in ischemic stroke (REBIOS) study.
    BMC Neurol. 2013;13:32.
  • Tokami H, Ago T, Sugimori H, Kuroda J, Awano H, Suzuki K, Kiyohara Y, Kamouchi M, Kitazono T; REBIOS Investigators.
    RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke.
    Brain Res. 2013;1517:122-32.
  • Nakamura A, Ago T, Kamouchi M, Hata J, Matsuo R, Kuroda J, Kuwashiro T, Sugimori H, Kitazono T; Fukuoka Stroke Registry Investigators.
    Intensity of anticoagulation and clinical outcomes in acute cardioembolic stroke: the Fukuoka Stroke Registry.
    Stroke. 2013;44(11):3239-42.
  • Kuwashiro T, Kamouchi M, Ago T, Hata J, Sugimori H, Kitazono T.
    The factors associated with a functional outcome after ischemic stroke in diabetic patients: the Fukuoka Stroke Registry.
    J Neurol Sci. 2012;313(1-2):110-4.
  • Kuwashiro T, Sugimori H, Ago T, Kamouchi M, Kitazono T; FSR Investigators.
    Risk factors predisposing to stroke recurrence within one year of non-cardioembolic stroke onset: the Fukuoka Stroke Registry.
    Cerebrovasc Dis. 2012;33(2):141-9.
  • Kamouchi M, Ueda K, Ago T, Nitta H, Kitazono T; Fukuoka Stroke Registry Investigators.
    Relationship between asian dust and ischemic stroke: a time-stratified case-crossover study.
    Stroke. 2012;43(11):3085-7.
  • Kamouchi M, Kumagai N, Okada Y, Origasa H, Yamaguchi T, Kitazono T.
    Risk score for predicting recurrence in patients with ischemic stroke: the Fukuoka stroke risk score for Japanese.
    Cerebrovasc Dis. 2012;34(5-6):351-7.
  • Kuwashiro T, Sugimori H, Kamouchi M, Ago T, Kitazono T, Iida M.
    Lower levels of high-density lipoprotein cholesterol on admission and a recurrence of ischemic stroke: a 12-month follow-up of the Fukuoka Stroke Registry.
    J Stroke Cerebrovasc Dis. 2012;21(7):561-8.
  • Kumai Y, Kamouchi M, Hata J, Ago T, Kitayama J, Nakane H, Sugimori H, Kitazono T; FSR Investigators.
    Proteinuria and clinical outcomes after ischemic stroke.
    Neurology. 2012;78(24):1909-15.